# Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

> **NCT01332201** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 17 (actual)

## Conditions studied

- Heart Transplantation
- Lung Transplantation
- Pancreas (Including SPK) Transplantation

## Interventions

- **DRUG:** Advagraf
- **DRUG:** Prograf

## Key facts

- **NCT ID:** NCT01332201
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332201, "Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01332201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*